Lindsay A Rhodes1, Shilpa Register1, Irfan Asif2, Gerald McGwin1,3, Jinan Saaddine4, Van Thi Ha Nghiem5, Cynthia Owsley1, Christopher A Girkin1. 1. Departments of Ophthalmology and Visual Sciences. 2. Family and Community Medicine, School of Medicine. 3. Departments of Epidemiology. 4. Vision Health Initiative, Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA. 5. Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL.
Abstract
PRCIS: This paper presents the methods and protocol of a community-based telemedicine program to identify glaucoma and other eye diseases. PURPOSE: To describe the study rationale and design of the Alabama Screening and Intervention for Glaucoma and eye Health through Telemedicine project. METHODS: The study will implement and evaluate a telemedicine-based detection strategy for glaucoma, diabetic retinopathy, and other eye diseases in at-risk patients seen at federally qualified health centers located in rural Alabama. The study will compare the effectiveness of the remote use of structural and functional ocular imaging devices to an in-person examination. Study participants will receive a remote ocular assessment consisting of visual acuity, intraocular pressure, visual field testing, and imaging of the retina and optic nerve with spectral-domain optical coherence tomography, and the data will be reviewed by an ophthalmologist and optometrist. It will also compare the effectiveness of financial incentives along with a validated patient education program versus a validated patient education program alone in improving follow-up adherence. Finally, cost and cost-effectiveness analyses will be performed on the telemedicine program compared with standard in-person care using effectiveness measured in numbers of detected eye disease cases. CONCLUSIONS: The study aims to develop a model eye health system using telemedicine to prevent vision loss and address eye health among underserved and at-risk populations.
PRCIS: This paper presents the methods and protocol of a community-based telemedicine program to identify glaucoma and other eye diseases. PURPOSE: To describe the study rationale and design of the Alabama Screening and Intervention for Glaucoma and eye Health through Telemedicine project. METHODS: The study will implement and evaluate a telemedicine-based detection strategy for glaucoma, diabetic retinopathy, and other eye diseases in at-risk patients seen at federally qualified health centers located in rural Alabama. The study will compare the effectiveness of the remote use of structural and functional ocular imaging devices to an in-person examination. Study participants will receive a remote ocular assessment consisting of visual acuity, intraocular pressure, visual field testing, and imaging of the retina and optic nerve with spectral-domain optical coherence tomography, and the data will be reviewed by an ophthalmologist and optometrist. It will also compare the effectiveness of financial incentives along with a validated patient education program versus a validated patient education program alone in improving follow-up adherence. Finally, cost and cost-effectiveness analyses will be performed on the telemedicine program compared with standard in-person care using effectiveness measured in numbers of detected eye disease cases. CONCLUSIONS: The study aims to develop a model eye health system using telemedicine to prevent vision loss and address eye health among underserved and at-risk populations.
Authors: K Yogesan; I J Constable; C J Barry; R H Eikelboom; W Morgan; M L Tay-Kearney; L Jitskaia Journal: J Glaucoma Date: 1999-10 Impact factor: 2.503
Authors: Cynthia Owsley; Gerald McGwin; Kay Scilley; Christopher A Girkin; Janice M Phillips; Karen Searcey Journal: Invest Ophthalmol Vis Sci Date: 2006-07 Impact factor: 4.799
Authors: Pamela A Sample; Felipe A Medeiros; Lyne Racette; John P Pascual; Catherine Boden; Linda M Zangwill; Christopher Bowd; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2006-08 Impact factor: 4.799
Authors: Nathan Congdon; Benita O'Colmain; Caroline C W Klaver; Ronald Klein; Beatriz Muñoz; David S Friedman; John Kempen; Hugh R Taylor; Paul Mitchell Journal: Arch Ophthalmol Date: 2004-04
Authors: Gergana Kodjebacheva; Anne L Coleman; Kristine E Ensrud; Jane A Cauley; Fei Yu; Katie L Stone; Kathryn L Pedula; Marc C Hochberg; Carol M Mangione Journal: Am J Ophthalmol Date: 2010-02 Impact factor: 5.258
Authors: Lindsay A Rhodes; Carrie E Huisingh; Gerald McGwin; Stephen T Mennemeyer; Mary Bregantini; Nita Patel; Jinan Saaddine; John E Crews; Christopher A Girkin; Cynthia Owsley Journal: Patient Relat Outcome Meas Date: 2016-05-19
Authors: Andrew Bastawrous; Mario Ettore Giardini; Nigel M Bolster; Tunde Peto; Nisha Shah; Iain A T Livingstone; Helen A Weiss; Sen Hu; Hillary Rono; Hannah Kuper; Matthew Burton Journal: JAMA Ophthalmol Date: 2016-02 Impact factor: 7.389